miR News & Events

Press Releases

October 13, 2020

miR Scientific announces FDA Breakthrough Device Designation for its Prostate Cancer Liquid Biopsy Test

September 14, 2020

miR Scientific's Breakthrough Sentinel Disease Management Platform Receives 2020 Innovation Award

September 8, 2020

miR Scientific on Yahoo Finance

August 10, 2020

miR Scientific Announces Validation of its Urine Based, Non-Invasive Prostate Cancer Test Published in the Journal of Urology

August 2, 2020

miR Scientific Named a Finalist in the Fierce Innovation Awards - Life Sciences Edition 2020

February 13, 2020

miR Scientific Presents Breakthrough New Data on the miR Scientific Sentinel™

January 21, 2020

miR Scientific® Introduces New Paradigm for Precision Medicine at PMWC 2020

March 18, 2019

miR Scientific Presents a New Non-invasive Test for Identifying Clinically Significant Prostate Cancer

July 20, 2018

miR Scientific to Present Novel Array Technologies for Diagnosis and Prognosis of Urogenital Cancers at the 2018 ASCO Annual Meeting

July 9, 2018

miR Scientific Appoints Laurence Klotz, M.D., FRCSC, as Chief Medical Officer

Media

August 14, 2020

Classification of Prostate Cancer Using Tests for Small Noncoding RNAs in Urinary Exosomes

August 11, 2020

Forbes: A Test Affecting Every Man’s Life Will Soon Be On The Market

April 6, 2020

miR Scientific Validates Urine-Based Cancer Tests, Awaits NYState Approval

March 6, 2020

3 New miR Scientific Urine Tests Diagnose, Classify Prostate Cancer, Data Shows

April 15, 2019

miR Scientific: Spotting Aggression With RNA in Urine

March 28, 2019

miR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer

October 4, 2018

miR Scientific Presents at 2018 World Urological Oncology Federation Conference

July 20, 2018

miR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data